跳至主要内容
临床试验/CTRI/2020/04/024690
CTRI/2020/04/024690尚未招募未知

Comparison of efficacy and safety of sertaconazole and clotrimazole pessaries in uncomplicated vulvovaginal candidiasis.

Pt B D Sharma PGIMS Rohtak0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients in reproductive age group (18-45 years).
  • Patients with clinical signs and symptoms of vulvovaginal candidiasis (complaints of vaginal pruritus, burning sensation, vulvar soreness or thick curdy discharge) with confirmed candidiasis on microscopic examination by potassium hydroxide (KOH) smear and gram staining.
  • Patients who are ready to give written informed consent.
  • Patients with less than three episodes of vulvovaginal candidiasis within previous year.

排除标准

  • Pregnant or lactating females.
  • Patients with history of previous treatment with systemic antifungal agents within past four weeks or previous topical antifungal treatment within one week.
  • Having any sexually transmitted disease or gynaecological abnormality requiring treatment.
  • History of diabetes mellitus
  • History of chronic illness.
  • Past history of hypersensitivity to imidazole agents.
  • Patients on immunosuppressant therapy.

研究者

相似试验